Latest
FDA Grants De Novo Classification to Neuropacs, Establishing New Category in Parkinsonian DiagnosticsFDA Grants De Novo Classification to Neuropacs, Establishing New Category in Parkinsonian Diagnostics|MaybernMaybern|Iterative Health Secures $77M in Series C Funding to Accelerate Clinical Trial InfrastructureIterative Health Secures $77M in Series C Funding to Accelerate Clinical Trial Infrastructure|Squads Secures $18M in Strategic Funding to Expand Stablecoin-Based Financial OSSquads Secures $18M in Strategic Funding to Expand Stablecoin-Based Financial OS|Blomma Secures $5M in Seed Funding to Build AI Career Coaching PlatformBlomma Secures $5M in Seed Funding to Build AI Career Coaching Platform|Dreambase Secures $3.7M in Seed Funding to Build AI-Native Analytics PlatformDreambase Secures $3.7M in Seed Funding to Build AI-Native Analytics Platform|Wet Hydration Secures $10M in Funding to Expand Functional Hydration BrandWet Hydration Secures $10M in Funding to Expand Functional Hydration Brand|Manifest OS Secures $60M in Series A Funding to Build AI-Native Legal InfrastructureManifest OS Secures $60M in Series A Funding to Build AI-Native Legal Infrastructure|Match Group Invests $100M in Sniffies to Expand Real-Time Location-Based Social PlatformMatch Group Invests $100M in Sniffies to Expand Real-Time Location-Based Social Platform|Hightouch Secures $150M in Series D Funding to Power AI-Driven Data ActivationHightouch Secures $150M in Series D Funding to Power AI-Driven Data Activation|FDA Grants De Novo Classification to Neuropacs, Establishing New Category in Parkinsonian DiagnosticsFDA Grants De Novo Classification to Neuropacs, Establishing New Category in Parkinsonian Diagnostics|MaybernMaybern|Iterative Health Secures $77M in Series C Funding to Accelerate Clinical Trial InfrastructureIterative Health Secures $77M in Series C Funding to Accelerate Clinical Trial Infrastructure|Squads Secures $18M in Strategic Funding to Expand Stablecoin-Based Financial OSSquads Secures $18M in Strategic Funding to Expand Stablecoin-Based Financial OS|Blomma Secures $5M in Seed Funding to Build AI Career Coaching PlatformBlomma Secures $5M in Seed Funding to Build AI Career Coaching Platform|Dreambase Secures $3.7M in Seed Funding to Build AI-Native Analytics PlatformDreambase Secures $3.7M in Seed Funding to Build AI-Native Analytics Platform|Wet Hydration Secures $10M in Funding to Expand Functional Hydration BrandWet Hydration Secures $10M in Funding to Expand Functional Hydration Brand|Manifest OS Secures $60M in Series A Funding to Build AI-Native Legal InfrastructureManifest OS Secures $60M in Series A Funding to Build AI-Native Legal Infrastructure|Match Group Invests $100M in Sniffies to Expand Real-Time Location-Based Social PlatformMatch Group Invests $100M in Sniffies to Expand Real-Time Location-Based Social Platform|Hightouch Secures $150M in Series D Funding to Power AI-Driven Data ActivationHightouch Secures $150M in Series D Funding to Power AI-Driven Data Activation
Back to articles

HSBC Invests in Candex to Expand Vendor Payment Platform

Funding Details

Amount

$40M

Round

Series C

You can tell a lot about a company by the problems it chooses to solve. Candex walked straight past the shiny stuff and into the operational grind most teams avoid. Not because it is glamorous, but because it is necessary. Tail spend, vendor chaos, payment friction. The kind of mess that quietly drains time, margin, and sanity if nobody steps in to own it.

Candex has extended its Series C to over $40M with a strategic investment from HSBC, pushing total funding north of $120M. This comes off a $33M Series C led by 9Yards Capital in 2025 and a $45M Series B led by Goldman Sachs Asset Management back in 2023. That is not random momentum. That is a pattern. Big money backing a company that understands a very unsexy truth. Tail spend is where discipline goes to die and where real operators quietly build leverage.

Credit where it is due. Jeremy Lappin, CEO and Co-Founder, has been playing a different game from the jump. While everyone else chased top line glory, Candex leaned into the operational underbelly. Vendor onboarding, payments, compliance. The stuff nobody brags about at conferences but everybody bleeds from internally. Turn that chaos into a single point of control and suddenly finance teams breathe differently. Procurement stops chasing ghosts. Suppliers actually get paid without friction. Funny how efficiency feels like magic when it is done right.

The platform is already trusted by hundreds of large multinational organizations including Diageo, Danone, Roche, and Sanofi. In 2025 alone, it supported well over $1B in payments. That is not just volume. That is proof that the model holds under real pressure, inside real enterprises, where complexity is not a feature, it is the default setting.

HSBC stepping in here is not just a capital move. It is signal. When an institution that size leans into your model, it means the pipes you are building are starting to look like infrastructure, not just software. And infrastructure companies do not shout. They compound.

The takeaway is simple, even if most will ignore it. There is a massive market in fixing what everyone else tolerates. Candex did not invent spend. They made it behave. That is a different kind of innovation. Less noise, more control. And in this market, control is currency.